Skip to content

Clinical trials

Observational Amyotrophic Lateral Sclerosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Observational Country / region: France Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20061
20131
20143
20151
20162
20171
20181
20201
20212
20221
20233
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting6
Terminated4
Not yet recruiting3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Limoges3
Assistance Publique - Hôpitaux de Paris2
Centre Hospitalier Universitaire Dijon2
Centre Hospitalier Universitaire de Nīmes2
Hospices Civils de Lyon2
Institut National de la Santé Et de la Recherche Médicale, France2
University Hospital, Clermont-Ferrand2
University Hospital, Tours2
Assistance Publique Hopitaux De Marseille1
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis29
Motor Neuron Disease3
Alzheimer Disease1
Brain Concussion1
Bulbo-Spinal Atrophy, X-Linked1
Disease1
Disease Progression1
Dysarthria1
Epilepsy1
Epilepsy, Temporal Lobe1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.